New study aims to predict and personalize diabetic retinopathy care

NCT ID NCT06821399

Recruiting now Knowledge-focused Sponsor: Yufan Wang Source: ClinicalTrials.gov ↗

First seen Apr 30, 2026 · Last updated Jun 11, 2026 · Updated 7 times

Summary

This study will enroll about 2,920 adults with type 2 diabetes to create an early warning system for diabetic retinopathy, an eye complication that can lead to blindness. Researchers will combine eye images, routine health tests, and metabolism markers to better predict who is at risk and tailor treatment. The goal is to improve monitoring and management of the disease at every stage.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Shanghai general hosptial
RECRUITING

Shanghai, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
The first hosptial of lanzhou university
RECRUITING

Lanzhou, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
The forth people's hosptial of shenyang
RECRUITING

Shenyang, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

diabetes mellitus diabetic retinopathy type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES DIABETES DIABETIC RETINOPATHY TYPE 2 DIABETES MELLITUS (T2DM)